Jane Street
ADMA icon

Jane Street’s ADMA Biologics ADMA Stock Holding History

Jane Street’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.36M Buy
595,400
+318,900
+115% +$5.03M ﹤0.01% 3404
2025
Q4 		$5.04M Sell
276,500
-7,700
-3% -$130K ﹤0.01% 3214
2025
Q3 		$4.17M Buy
284,200
+47,300
+20% +$811K ﹤0.01% 3691
2025
Q2 		$4.31M Sell
236,900
-155,600
-40% -$3.17M ﹤0.01% 3203
2025
Q1 		$7.79M Buy
392,500
+266,800
+212% +$4.61M ﹤0.01% 2316
2024
Q4 		$2.16M Buy
125,700
+72,900
+138% +$1.37M ﹤0.01% 3978
2024
Q3 		$1.06M Buy
52,800
+1,000
+2% +$15.6K ﹤0.01% 5779
2024
Q2 		$579K Buy
51,800
+9,200
+22% +$77.2K ﹤0.01% 6768
2024
Q1 		$281K Buy
42,600
+28,300
+198% +$155K ﹤0.01% 7662
2023
Q4 		$64.6K Sell
14,300
-4,800
-25% -$17.8K ﹤0.01% 8714
2023
Q3 		$68.4K Sell
19,100
-85,000
-82% -$327K ﹤0.01% 8077
2023
Q2 		$384K Buy
104,100
+5,500
+6% +$20.4K ﹤0.01% 6722
2023
Q1 		$326K Sell
98,600
-300,000
-75% -$1.04M ﹤0.01% 7054
2022
Q4 		$1.55M Buy
398,600
+305,500
+328% +$942K ﹤0.01% 4268
2022
Q3 		$226K Buy
93,100
+58,500
+169% +$140K ﹤0.01% 7985
2022
Q2 		$69K Buy
+34,600
New +$68.1K ﹤0.01% 8810
2022
Q1 		– Sell
-13,900
Closed -$20K – 10188
2021
Q4 		$20K Buy
+13,900
New +$18.3K ﹤0.01% 9790
2020
Q3 		– Sell
-10,400
Closed -$30K – 7074
2020
Q2 		$30K Buy
+10,400
New +$29.9K ﹤0.01% 6935

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Jane Street's ADMA Position: Q1 2026 in Review

Jane Street increased its ADMA Biologics (ADMA) stake by 564% in Q1 2026, buying an estimated $40.9M and bringing the position to 3,051,943 shares worth $27.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1510.

Jane Street first reported a position in ADMA in Q1 2019 and has held it in 25 quarters since. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Jane Street held 3,051,943 shares of ADMA Biologics worth $27.5M as of Q1 2026.
  • Jane Street bought 2,592,519 ADMA Biologics shares in Q1 2026, an estimated $40.9M.
  • ADMA Biologics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #1510 holding.
  • Jane Street first reported a position in ADMA Biologics in Q1 2019 and has held it in 25 quarters since.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.